Amicus Therapeutics Inc (FOLD)
10.52
-0.14
(-1.31%)
USD |
NASDAQ |
Apr 16, 14:44
Amicus Therapeutics Cash from Operations (TTM): -69.09M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -69.09M |
| September 30, 2023 | -153.32M |
| June 30, 2023 | -126.60M |
| March 31, 2023 | -126.33M |
| December 31, 2022 | -166.58M |
| September 30, 2022 | -156.32M |
| June 30, 2022 | -168.39M |
| March 31, 2022 | -188.45M |
| December 31, 2021 | -202.49M |
| September 30, 2021 | -181.80M |
| June 30, 2021 | -200.11M |
| March 31, 2021 | -197.70M |
| December 31, 2020 | -233.29M |
| September 30, 2020 | -241.30M |
| June 30, 2020 | -254.84M |
| March 31, 2020 | -279.81M |
| December 31, 2019 | -250.42M |
| September 30, 2019 | -253.26M |
| June 30, 2019 | -330.47M |
| March 31, 2019 | -328.98M |
| December 31, 2018 | -299.96M |
| September 30, 2018 | -312.31M |
| June 30, 2018 | -228.45M |
| March 31, 2018 | -213.37M |
| December 31, 2017 | -213.70M |
| Date | Value |
|---|---|
| September 30, 2017 | -172.26M |
| June 30, 2017 | -164.23M |
| March 31, 2017 | -155.05M |
| December 31, 2016 | -150.15M |
| September 30, 2016 | -154.06M |
| June 30, 2016 | -134.20M |
| March 31, 2016 | -124.10M |
| December 31, 2015 | -100.14M |
| September 30, 2015 | -79.14M |
| June 30, 2015 | -73.24M |
| March 31, 2015 | -62.42M |
| December 31, 2014 | -51.67M |
| September 30, 2014 | -45.28M |
| June 30, 2014 | -43.67M |
| March 31, 2014 | -42.11M |
| December 31, 2013 | -45.79M |
| September 30, 2013 | -45.05M |
| June 30, 2013 | -38.74M |
| March 31, 2013 | -39.60M |
| December 31, 2012 | -33.74M |
| September 30, 2012 | -38.89M |
| June 30, 2012 | -44.68M |
| March 31, 2012 | -44.16M |
| December 31, 2011 | -49.42M |
| September 30, 2011 | -14.54M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-330.47M
Minimum
Jun 2019
-69.09M
Maximum
Dec 2023
-198.98M
Average
-197.70M
Median
Mar 2021
Cash from Operations (TTM) Benchmarks
| TG Therapeutics Inc | -31.41M |
| Geron Corp | -167.74M |
| Vanda Pharmaceuticals Inc | 12.80M |
| Fate Therapeutics Inc | -132.26M |
| Editas Medicine Inc | -132.18M |